Kenvue Inc (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson (NYSE:JNJ) in 2023, is considering selling a selection of its smaller skin health and beauty brands to streamline this segment and refocus on its core products, according to a Reuters report. The report, which cited four people with knowledge of the matter, is considering the sale of brands such as Clean & Clear, Maui Moisture, Neostrata, its German baby care brand Bebe, and Japanese brand Dr.Ci:Labo.
PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Kenvue Inc. (NYSE:KVUE) on behalf of the company's long-term investors. Click here to receive additional information about your legal rights and options: Click Here Recently a securities fraud complaint was filed against Kenvue on behalf of investors who purchased or acquired shares of the company's stock between May 8, 2023 and September 12, 2023.
I initiate Kenvue with a 'Buy' rating and a $26 fair value, citing its iconic brands and steady dividend appeal. Kenvue's global operations, diversified product lines, and strong R&D enable resilience and ongoing margin expansion through cost efficiencies. Short-term headwinds from China destocking and tariffs are manageable, with long-term organic growth expected to normalize at 4.5%.
![]() KVUE In 1 month Estimated | Quarterly | $0.2 Per Share |
![]() KVUE 1 month ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 4 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 7 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 10 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 7 May 2024 Paid | Quarterly | $0.2 Per Share |
5 May 2025 Date | | 0.23 Cons. EPS | 0.24 EPS |
6 Feb 2025 Date | | 0.31 Cons. EPS | 0.26 EPS |
7 Nov 2024 Date | | 0.27 Cons. EPS | 0.28 EPS |
6 Aug 2024 Date | | 0.28 Cons. EPS | 0.32 EPS |
7 May 2024 Date | | 0.25 Cons. EPS | 0.28 EPS |
![]() KVUE In 1 month Estimated | Quarterly | $0.2 Per Share |
![]() KVUE 1 month ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 4 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 7 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 10 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 7 May 2024 Paid | Quarterly | $0.2 Per Share |
5 May 2025 Date | | 0.23 Cons. EPS | 0.24 EPS |
6 Feb 2025 Date | | 0.31 Cons. EPS | 0.26 EPS |
7 Nov 2024 Date | | 0.27 Cons. EPS | 0.28 EPS |
6 Aug 2024 Date | | 0.28 Cons. EPS | 0.32 EPS |
7 May 2024 Date | | 0.25 Cons. EPS | 0.28 EPS |
Household & Personal Products Industry | Consumer Defensive Sector | Mr. Thibaut Mongon CEO | XDUS Exchange | US49177J1025 ISIN |
US Country | 22,000 Employees | 14 May 2025 Last Dividend | - Last Split | 4 May 2023 IPO Date |
Kenvue Inc. is a global consumer health firm that offers a wide range of healthcare products through its diverse operational segments: Self Care, Skin Health and Beauty, and Essential Health. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue Inc. delivers a comprehensive portfolio of products designed to improve the wellness and health of consumers around the world. By leveraging well-known brands across its segments, Kenvue provides solutions for everyday health concerns, from pain relief and cold prevention to skincare and baby care.